Golden State Medical Supply Inc.: Drug Recall
Recall #D-0568-2024 · 05/13/2024
Class II: Risk
Recall Details
- Recall Number
- D-0568-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Golden State Medical Supply Inc.
- Status
- Terminated
- Date Initiated
- 05/13/2024
- Location
- Camarillo, CA, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 21,655 (30 count bottle), 34,149 (90 count bottle)
Reason for Recall
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the proposed interim limit.
Product Description
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, a) 30 capsules bottles, NDC 60429-165-30; b) 90 capsules bottles, NDC 60429-165-90, Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Packaged by GSMS, Incorporated, Camarillo, CA 93012.
Distribution Pattern
Nationwide in the U.S.
Other Recalls by Golden State Medical Supply Inc.
- Class II: Risk 11/26/2025
- Class II: Risk 10/20/2025
- Class II: Risk 03/05/2025
- Class II: Risk 02/14/2024
- Class II: Risk 01/12/2024
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.